Focal Biosciences is a startup based in Switzerland.
Based in Switzerland, Focal Biosciences is a startup.
Focal Biosciences develops a platform and pipeline leveraging chromatin fingerprint technology and AI to discover drugs that reprogram cells at the epigenetic level to treat and potentially reverse chronic and age-related diseases, focusing initially on fibrotic diseases.
Funding rounds, investor list, risk signals, and comparable startups, all gated to subscribers.